NP Life Sciences Health Industry Group Inc.
Close on Oct 19, 2026
- Market cap
- $429.60M
- P/E (TTM)
- –
- Dividend yield
- –
About NP Life Sciences Health Industry
Services-Educational Services, SIC 8200
NP Life Sciences Health Industry Group Inc. provides educational and cultural services focused on classical Chinese studies and culture. The company delivers language and cultural training courses in both Chinese and English, coordinates international study tours between the United States and China, and organizes cultural exhibitions and art fairs. Additionally, through its subsidiary GW Health Consulting Management, it offers career planning guidance and consulting services. The organization primarily serves Chinese-Americans, students across various age groups, academic scholars, and members of the public seeking engagement with traditional Chinese heritage.
The company is headquartered in Danville, California, and maintains cooperative agency relationships within California and in Shaanxi, China. Its operations encompass subsidiaries registered in California, Hong Kong, and Singapore. The business collaborates with partner institutions and cultural specialists in China to support its educational offerings and cross-border exchange programs.
Summary of the business section of NP Life Sciences Health Industry's latest annual report, written by StockData.
Company profile
Company
- Legal name
- NP Life Sciences Health Industry Group Inc.
- Founded
- 2018
- Headquarters
- Danville, CA
- Address
- 4125 Blackhawk Plaza Circle, Suite 166 94506
- Phone
- (925) 362-3169
- Industry
- Services-Educational Services
- Incorporated in
- Nevada
- Fiscal year ends
- December 31
- Auditor
- WWC, P.C., San Mateo, CA
Stock & identifiers
- Ticker
- ACAT
- Exchange
- OTC
- Shares outstanding
- 43M, Apr 15, 2024
- Filer category
- Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Stock splits
- 1-for-10 reverse, Oct 28, 2025
- SEC CIK
- 1781726
- EIN
- 83-2912878
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
No recent ownership filings by officers or directors
NP Life Sciences Health Industry's leadership is listed in its proxy statement (Form DEF 14A).
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Aug 21, 2024 | Deregistration | Termination of SEC registration (Form 15) |
| May 15, 2024 | Deregistration | Termination of SEC registration (Form 15) |
| Apr 2, 2024 | Late filing | Notification of late filing |
| Apr 3, 2023 | Late filing | Notification of late filing |
| Sep 29, 2022 | Name change | Name changed from GJ Culture Group US, Inc. to NP Life Sciences Health Industry Group Inc. |
| May 17, 2022 | Late filing | Notification of late filing |
| Mar 16, 2022 | Late filing | Notification of late filing |
| Nov 16, 2021 | Late filing | Notification of late filing |
| Apr 1, 2021 | Late filing | Notification of late filing |
| Nov 15, 2019 | Late filing | Notification of late filing |